Cabaletta Bio, Inc.
Company Stats
- Market Cap
- $325.5M
- as of Sep 30, 2026
- Shares Outstanding
- 169.5M
- Free Float
- 99.4%
Income Statement
- Operating Income
- -$172.2M
- Net Income
- -$167.9M
- EBITDA
- -$170.6M
Cash Flow
- Free Cash Flow
- -$132.3M
- FCF Yield
- -40.6%
- Owner FCF Yield
- -47.1%
Balance Sheet
- Cash & Equivalents
- $83.0M
Returns & Capital
- SBC, 3Y Avg
- $17.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$132.3M | — |
| FY2024 | — | -$90.4M | — |
| FY2023 | — | -$54.2M | — |
| FY2022 | — | -$48.8M | — |
| FY2021 | — | -$35.3M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges